Laura B Teal

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Mesenchymal Stem Cells

High Fat Diet Induced

Mild Cognitive Impairment

Cognitive Decline

Top Venues

ACS chemical neuroscience

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Jason K Russell, Shalonda M Ingram, Laura B Teal, Dennis C Liotta, Carrie K Jones
M 1 /M 4 -Preferring Muscarinic Cholinergic Receptor Agonist Xanomeline Reverses Wake and Arousal Deficits in Nonpathologically Aged Mice. ACS chemical neuroscience 14 (3) (2023)
Aaron T Garrison, Douglas L Orsi, Rory A Capstick, David Whomble, Jinming Li, Trever R Carter, Andrew S Felts, Paige N Vinson, Alice L Rodriguez, Allie Han, Krishma Hajari, Hyekyung P Cho, Laura B Teal, Madeline G Ragland, Masoud Ghamari-Langroudi, Michael Bubser, Sichen Chang, Nathalie C Schnetz-Boutaud, Olivier Boutaud, Anna L Blobaum, Daniel J Foster, Colleen M Niswender, P Jeffrey Conn, Dennis C Liotta, Carrie K Jones, Changho Han
Development of VU6019650 : A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M 5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder. Journal of medicinal chemistry 65 (8) (2022)